Francis Richard D Insider Trades

Insider Trading History

Track insider trading activity for Francis Richard D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $37.2M 1,177,529 shares
Last Trade
Jun 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$211k 6,153 shares
$34.35
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $37.4M 1,183,682 shares
Last Trade
Jun 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$446k 13,043 shares
$34.19
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $1.23M 39,130 shares
Last Trade
Jun 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$446k 13,043 shares
$34.19
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $4.02M 127,359 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.35M 42,452 shares
$31.76
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $37.6M 1,190,664 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.35M 42,452 shares
$31.76
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $36.9M 1,170,639 shares
Last Trade
Mar 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$634k 20,025 shares
$31.67
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $3.17M 100,446 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65M 50,223 shares
$32.90
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $4.32M 136,736 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.5M 136,736 shares
$32.90
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $36.2M 1,148,212 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$759k 23,393 shares
$32.46
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $37M 1,171,605 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65M 50,223 shares
$32.90
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $2.12M 67,231 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30.9M 958,546 shares
$32.26
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $35.4M 1,121,382 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.3M 442,935 shares
$32.36
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $48.4M 1,533,414 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30.9M 958,546 shares
$32.26
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $28.1M 891,893 shares
Last Trade
Feb 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.6M 781,766 shares
$33.98
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $0 0 shares
Last Trade
Feb 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.1M 620,110 shares
$33.98
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $19.1M 605,771 shares
Last Trade
Feb 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.3M 447,778 shares
$34.22
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $28.1M 891,315 shares
Last Trade
Jan 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.2M 1,511,425 shares
$31.90
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $1.65M 52,173 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$900k 52,173 shares
$17.25
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $8.58M 271,783 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$131k 8,259 shares
$15.91
$31.56
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
President And CEO
Holding Value $5.36M 169,811 shares
Last Trade
Mar 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.7M 169,811 shares
$15.90
$31.56

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up